Robert G. Pietrusko
General Counsel at VOR BIOPHARMA INC.
Profile
Robert G.
Pietrusko is currently the Chief Regulatory & Quality Officer at Vor Biopharma, Inc. Prior to this, he was the SVP-Regulatory Affairs & Quality Assurance at Voyager Therapeutics, Inc. from 2014 to 2020.
He was also the Senior Vice President-Worldwide Regulatory Affairs at Millennium Pharmaceuticals, Inc. from 2001 to 2007, Vice President-Regulatory Affairs at Shire ViroPharma, Inc. from 2007 to 2009, and Vice President-Regulatory Affairs at GSK Plc from 1999 to 2000.
Dr. Pietrusko received his undergraduate degree from Rutgers State University of New Jersey and his doctorate degree from Philadelphia College of Pharmacy.
Robert G. Pietrusko active positions
Companies | Position | Start |
---|---|---|
VOR BIOPHARMA INC. | General Counsel | 31/03/2020 |
Former positions of Robert G. Pietrusko
Companies | Position | End |
---|---|---|
VOYAGER THERAPEUTICS, INC. | General Counsel | 29/02/2020 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | General Counsel | 30/04/2007 |
GSK PLC | General Counsel | 31/12/1999 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | General Counsel | - |
Training of Robert G. Pietrusko
Rutgers State University of New Jersey | Undergraduate Degree |
Philadelphia College of Pharmacy | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
GSK PLC | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
VOR BIOPHARMA INC. | Health Technology |
Private companies | 2 |
---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Robert G. Pietrusko